Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | ARORA BROS MEDILINKERSLikely | 10 | ₹11,622 |
| 2 | Schedule 2 | SUKUN PHARMALikely | 14 | ₹5,652 |
| 3 | Schedule 3 | SAHARA PHARMACYLikely | 9 | ₹18,810 |
| 4 | Schedule 4 | SUNIL PHARMACYLikely | 10 | ₹12,640 |
| 5 | Schedule 5 | JEEVAN RAKSHA AUSHADI PRIVATE LIMITEDLikely | 3 | ₹15,300 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
29 Jun 2026, 12:00 pmClosed
ECHS CFA RE 59
9473900
GEM/2026/B/7669298
Two Packet Bid
SUMATRIPTAN 50 MG TAB,TRIHEXYPHENIDYL 2MG TAB,VALACYCLOVIR 500 MG TAB,MESALAMINE 5-AMINO SALICYLIC
Central Delhi, Delhi
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
10%
Exempted
Yes
29 Jun 2026
16 Jun 2026
29 Jun 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | SUMATRIPTAN 50 MG TAB | 3,900 | No | Central Delhi | 15 |
| 2 | TRIHEXYPHENIDYL 2MG TAB | 31,400 | No | Central Delhi | 15 |
| 3 | VALACYCLOVIR 500 MG TAB | 1,980 | No | Central Delhi | 15 |
| 4 | MESALAMINE 5-AMINO SALICYLIC ACID 400 MG DELAYED RELEASE TAB | 8,000 | No | Central Delhi | 15 |
| 5 | ACEBROPHYLLINE 200 MG PLUS FEXOFENADINE 120 MG PLUS MONTELUKAST 10 MG TAB | 3,400 | No | Central Delhi | 15 |
| 6 | ACEBROPHYLLINE 100 MG TAB | 1,09,400 | No | Central Delhi | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9473900.pdf
GEM_BID • 0.12 MB
img_0013_2026-06-16-11-52-12_a2c81cdca2dd1616393c52a55c3e209c.pdf
BOQ • 0.49 MB
boq_item_sample_file_2026-06-16-11-52-12_e7d6873d37cee908139a3c87f5a210b9.csv
BOQ • 0.00 MB
GEM_OTHER • 1.82 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .